Background: Whether people experiencing homelessness (PEH) have different COVID-19 outcomes than housed patients in Canada remains unclear. We sought to ascertain whether rates of in-hospital ...
Outcomes for people experiencing homelessness with COVID-19 presenting to emergency departments in Canada, compared with housed patients ...
Five Things to Know About ...: Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes ...
La voix était perçante, fendant l’air du matin paisible. Quand je l’ai entendue, je m’apprêtais à fermer la portière de ma voiture au niveau supérieur du garage à étages de l’hôpital. Un homme ...
Sodium–glucose cotransporter 2 (SGLT2) inhibitors and risk of chronic kidney disease–mineral and bone disorders in patients with type 2 diabetes mellitus and stage 1–3 chronic kidney disease ...
Les agonistes du récepteur du peptide-1 de type glucagon (GLP-1) sont utilisés pour le traitement du diabète, de l’obésité, et du syndrome des ovaires polykystiques (SOPK) Le sémaglutide, le ...
Background: Although clinical trials involving psychedelic-assisted psychotherapy have not observed short-term increases in ...
As a composer, I have channelled emotions into art for as long as I can remember. When death was still only an abstract concept to me, I approached it with tentative curiosity. I allowed myself to ...